Functional Collaboration of Insulin-Like Growth Factor-1 Receptor (IGF-1R), but Not Insulin Receptor (IR), With Acute GH Signaling in Mouse Calvarial Cells

被引:10
|
作者
Gan, Yujun [1 ]
Paterson, Andrew J. [1 ]
Zhang, Yue [1 ]
Jiang, Jing [1 ]
Frank, Stuart J. [1 ,2 ,3 ,4 ]
机构
[1] Univ Alabama Birmingham, Dept Med, Birmingham, AL 35294 USA
[2] Univ Alabama Birmingham, Div Endocrinol Diabet & Metab, Birmingham, AL 35294 USA
[3] Univ Alabama Birmingham, Dept Cell Dev & Integrat Biol, Birmingham, AL 35294 USA
[4] Vet Affairs Med Ctr, Med Serv, Endocrinol Sect, Birmingham, AL 35233 USA
基金
美国国家卫生研究院;
关键词
1ST; 3; DOMAINS; HORMONE RECEPTOR; SOMATOMEDIN HYPOTHESIS; PROSTATE CARCINOGENESIS; SPECIFICITY; OSTEOBLASTS; DISRUPTION; RAT; TRANSCRIPTION; DETERMINANTS;
D O I
10.1210/en.2013-1732
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
GH signals through the GH receptor (GHR), a cytokine receptor linked to Janus kinase 2 (JAK2). GH activates signal transducer and activator of transcription 5 (STAT5), causing expression of genes including IGF-I. IGF-I binds IGF-I receptor (IGF-IR), a heterotetrameric (alpha(2)-beta(2)) tyrosine kinase growth factor receptor similar to insulin receptor (IR). In addition to this GH -> GHR -> IGF-I -> IGF-IR pathway, GH induces a complex including GHR, JAK2, and IGF-IR and deletion of floxed IGF-1R in primary murine calvarial cells with Cre-recombinase-expressing adenovirus (Ad-Cre) desensitizes cells to GH for STAT5 activation and IGF-I mRNA accumulation. Diminished GH-induced STAT5 phosphorylation in Ad-Cre-treated cells is rescued by adenoviruses encoding either IGF-IR or IGF-IR lacking the alpha-chain intracellular domain. Reasoning that IGF-IR's extracellular portion (alpha or extracellular beta) mediates functional interaction with GH signaling, we pursued reconstitution studies. Although structurally related to IGF-IR, IR expressed adenovirally did not rescue GH-induced STAT5 phosphorylation in Ad-Cre-treated cells. We thus created chimeras, swapping homologous IR extracellular regions into IGF-IR. IR and IGF-IR possess N-terminal L1, cysteine-rich (CR), and L2 alpha-chain domains. We created Ad-IGF-IR/IR-L1 and Ad-IGF-IR/IR-L1-CR-L2, in which L1 alone or L1, CR, and L2 of IR replace corresponding IGF-IR regions, respectively. Ad-IGF-IR/IR-L1, but not Ad-IGF-IR/IRL1- CR-L2, rescued GH-induced STAT5 phosphorylation in Ad-Cre-treated cells. Additionally, medium containing a soluble IGF-IR (including only L1-CR-L2) dampened GH-induced STAT5 phosphorylation in calvarial cells and two other GH-responsive cell lines. Thus, an extracellular determinant(s), likely in CR-L2, specifically allows IGF-IR to collaborate with GHR and JAK2 for robust GH-induced acute STAT5 phosphorylation.
引用
收藏
页码:1000 / 1009
页数:10
相关论文
共 50 条
  • [21] A highly selective dual insulin receptor (IR)/insulin-like growth factor 1 receptor (IGF-1R) inhibitor derived from an ERK inhibitor.
    Duong-Ly, Krisna C.
    Anastassiadis, Theonie
    Deacon, Sean W.
    Lafontant, Alec
    Ma, Haiching
    Devarajan, Karthik
    Dunbrack, Roland L.
    Wu, Jinhua
    Peterson, Jeffrey R.
    [J]. MOLECULAR CANCER THERAPEUTICS, 2013, 12 (11)
  • [22] Serum antibodies against the insulin-like growth factor-1 receptor (IGF-1R) in Graves' disease and Graves' orbitopathy
    Marino, M.
    Dottore, G. Rotondo
    Ionni, I.
    Lanzolla, G.
    Sabini, E.
    Ricci, D.
    Sframeli, A.
    Mazzi, B.
    Menconi, F.
    Latrofa, F.
    Vitti, P.
    Marcocci, C.
    Chiovato, L.
    [J]. JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION, 2019, 42 (04) : 471 - 480
  • [23] Serum antibodies against the insulin-like growth factor-1 receptor (IGF-1R) in Graves’ disease and Graves’ orbitopathy
    M. Marinò
    G. Rotondo Dottore
    I. Ionni
    G. Lanzolla
    E. Sabini
    D. Ricci
    A. Sframeli
    B. Mazzi
    F. Menconi
    F. Latrofa
    P. Vitti
    C. Marcocci
    L. Chiovato
    [J]. Journal of Endocrinological Investigation, 2019, 42 : 471 - 480
  • [24] Insulin-Like Growth Factor-1 Receptor (IGF-1R) and Its Inhibition in Non-Functioning Neuroendocrine Tumors
    Sasano, H.
    Iida, S.
    Ono, K.
    Nakamura, Y.
    Miki, Y.
    [J]. NEUROENDOCRINOLOGY, 2011, 94 : 10 - 10
  • [25] Discovery and optimization of imidazo[1,2-α]pyridine inhibitors of insulin-like growth factor-1 receptor (IGF-1R)
    Emmitte, Kyle A.
    Wilson, Brian J.
    Baum, Erich W.
    Emerson, Holly K.
    Kuntz, Kevin W.
    Nailor, Kristen E.
    Salovich, James M.
    Smith, Stephon C.
    Cheung, Mui
    Gerding, Roseanne M.
    Stevens, Kirk L.
    Uehling, David E.
    Mook, Robert A., Jr.
    Moorthy, Ganesh S.
    Dickerson, Scott H.
    Hassell, Anne M.
    Leesnitzer, M. Anthony
    Shewchuk, Lisa M.
    Groy, Arthur
    Rowand, Jason L.
    Anderson, Kelly
    Atkins, Charity L.
    Yang, Jingsong
    Sabbatini, Peter
    Kumar, Rakesh
    [J]. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2009, 19 (03) : 1004 - 1008
  • [26] Immunolocalization of the insulin like growth factor-1 (IGF-1) and IGF-1 receptor (IGF-1R) in the ovary of the bitch
    Cardilli, D. J.
    Oliveira, K. S.
    Joao, C. F.
    Voorwald, F. A.
    Silva, M. A. M.
    Oliveria, J. A.
    Toniollo, G. H.
    Perez-Gutierrez, J. F.
    [J]. REPRODUCTION IN DOMESTIC ANIMALS, 2012, 47 : 116 - 117
  • [27] Insulin-like growth factor 1 receptor (IGF-1R) as a target for treatment of metastatic uveal melanoma
    Yoshida, Makoto
    Baserga, Renato
    Terai, Mizue
    Mastrangelo, Michael J.
    Sato, Takami
    [J]. CANCER RESEARCH, 2010, 70
  • [28] Clinical development of insulin-like growth factor receptor-1 (IGF-1R) inhibitors: At the crossroad?
    Gombos, Andrea
    Metzger-Filho, Otto
    Dal Lago, Lissandra
    Awada-Hussein, Ahmad
    [J]. INVESTIGATIONAL NEW DRUGS, 2012, 30 (06) : 2433 - 2442
  • [29] Expression of insulin-like growth factor-1 receptor (IGF-1R) as a marker of response to erlotinib in pancreatic ductal adenocarcinoma (PDA).
    Witkiewicz, A.
    Valsecchi, M. E.
    Brody, J. R.
    Simon, L. R.
    Yeo, C.
    Carr, B. I.
    Solomides, C.
    Peiper, S.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
  • [30] IMMUNOHISTOCHEMICAL EXPRESSION OF INSULIN-LIKE GROWTH FACTOR-1 RECEPTOR (IGF-1R) AND ITS ASSOCIATION WITH CLINICOPATHOLOGICAL PARAMETERS IN HEPATOCELLULAR CARCINOMA
    Maia, Maria Luiza Peloso
    Albuquerque, Ronniel Morais
    do Carmo Silva, Serena Dafne
    Lima, Cristiano Xavier
    Diniz, Paulo Henrique Costa
    Vidgal, Paula Vieira Teixeira
    [J]. ONCOLOGY, 2024, 102 (06): : 494 - 502